Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A tumor cell with neuroendocrine features is a neoplastic cell displaying characteristics of both the endocrine and nervous systems. These cells are defined by their ability to produce peptide hormones or bioamines and express neuroendocrine markers like chromogranin A, synaptophysin and INSM1. They are classified based on differentiation and grade (well-differentiated NETs vs. poorly differentiated NECs), influencing prognosis and treatment strategies. The presence of neuroendocrine features can also arise through transdifferentiation, a process associated with therapy resistance.
Varied depending on the specific tumor and treatment; somatostatin analogs bind to somatostatin receptors, chemotherapy induces cell death.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell with Neuroendocrine Features (NET Cell).